BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for the Mahamaya Lifesciences IPO

Mahamaya Lifesciences Limited, incorporated in 2002, operates in the agrochemical industry with a focus on developing and exporting crop protection products and bioproducts. The company’s core business involves manufacturing pesticide formulations, importing vital technical molecules, and registering them with the Central Insecticides Board before marketing them as value-added products. It caters to both domestic agrochemical manufacturers and multinational corporations, ensuring quality and compliance at every stage. With a diverse product range that includes insecticides, herbicides, and biopesticides, Mahamaya Lifesciences aims to contribute to agricultural sustainability and improved crop productivity. Over the years, the company has built a strong foothold in both Indian and international markets, with active exports to several countries across Asia, Africa, and the Middle East. Its continuous investment in product research, formulation innovation, and global registrations has helped it maintain a competitive position in the agrochemical segment.

Investors can apply for the Mahamaya Lifesciences IPO through their bank’s net banking facility using the ASBA (Application Supported by Blocked Amount) option or via online trading platforms provided by their brokers. To apply, investors must log in to their demat or trading account, select the IPO section, and choose “Mahamaya Lifesciences Limited.” After entering bid details such as the quantity and price within the given range, confirm and submit the application. Once submitted, the bid amount will be blocked in the applicant’s bank account until allotment, after which the shares will be credited to the demat account if allotted.

For more details, visit the Mahamaya Lifesciences IPO page.

Mahamaya Lifesciences IPO Details and Objectives

Details

Information

IPO Date

November 11, 2025 to November 13, 2025

Issue Size

61,78,800 shares

(aggregating up to ₹70.44 Cr)

Price Band

₹108 to ₹114 per share

Lot Size

1200 shares

Listing At

BSE SME

Market Maker

Mansi Share & Stock Broking Pvt.Ltd.

Purpose of the IPO

  • Purchase of Equipment for existing Formulation plant

  • Funding capital expenditure towards setting up of a new technical manufacturing plant.

  • Construction of Warehouse Building and Purchase of Machinery

  • Funding working capital requirement of the Company

  • General Corporate purposes

Timeline of Mahamaya Lifesciences IPO

Event

Date

IPO Open Date

Tue, Nov 11, 2025

IPO Close Date

Thu, Nov 13, 2025

Tentative Allotment

Fri, Nov 14, 2025

Initiation of Refunds

Mon, Nov 17, 2025

Credit of Shares to Demat

Mon, Nov 17, 2025

Tentative Listing Date

Tue, Nov 18, 2025

Cut-off time for UPI mandate confirmation

5 PM on Thu, Nov 13, 2025

Pricing & Lot Size of Mahamaya Lifesciences IPO

Price Band for the IPO

  •  ₹108 to ₹114 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Individual investors (Retail) (Min)

2

2,400

₹2,73,600

Individual investors (Retail) (Max)

2

2,400

₹2,73,600

S-HNI (Min)

3

3,600

₹4,10,400

S-HNI (Max)

7

8,400

₹9,57,600

B-HNI (Min)

8

9,600

₹10,94,400

Mahamaya Lifesciences IPO Application Process

The Mahamaya Lifesciences IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using the broker's app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Mahamaya Lifesciences IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (minimum lot size: 1200 shares) within the price band of ₹108 to ₹114 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹77.88 crore in FY23 to ₹218.87 crore as of June 2025.

  • Total income: Reached ₹84.04 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹4.10 crore for June 2025.

  • Net Worth: Recorded at ₹53.50 crore in FY25.

  • Reserves and Surplus: Recorded at ₹35.73 crore (June 2025), growing steadily over the years.

  • EBITDA: Stood at ₹8.04 crore in June 2025.

Recent Performance and Growth Prospects

  • The company has witnessed consistent growth in its asset base, reflecting expansion in its overall operations and resource capacity.

  • Its total income has shown a steady upward movement, indicating strong business performance and improved revenue generation.

  • Profitability has remained stable, supported by efficient cost management and operational effectiveness.

  • The company’s net worth has strengthened over time, showcasing a healthy financial position and sound capital structure.

  • Reserves and surplus have continued to grow, reflecting retained earnings and a focus on long-term sustainability.

  • The company’s operating performance has improved, as seen in its positive earnings before interest, tax, depreciation, and amortisation, highlighting operational efficiency and business resilience.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company operates in the agrochemical sector, which is influenced by environmental regulations, weather conditions, and changing government policies that can affect demand and production cycles.

  • Dependence on imported raw materials and technical molecules exposes the company to supply chain disruptions, currency fluctuations, and geopolitical risks that may impact cost efficiency.

Opportunities and Growth Potential

  • Mahamaya Lifesciences has a diversified product portfolio and a growing international presence, positioning it to capitalise on the increasing global demand for sustainable crop protection solutions.

  • Planned investments from the IPO proceeds, such as setting up a new technical manufacturing plant and expanding warehouse capacity, are expected to enhance production capabilities and strengthen its market reach.

Key Performance Indicator (KPI)

KPI

Values

ROE

34.94%

ROCE

23.15%

Debt/Equity

1.08

RoNW

26.19%

PAT Margin

4.84%

EBITDA Margin

9.22%

Price to Book Value

9.40

Market Capitalization

266.82

Mahamaya Lifesciences IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Kfin Technologies Ltd. 

Oneview Corporate Advisors Pvt.Ltd.

Company Address of Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Ltd. Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1 Delhi, New Delhi, 110020

Phone: +91-1146561474

Email: cs@mahamayalifesciences.com

Website: https://www.mahamayalifesciences.com/

Conclusion

In conclusion, Mahamaya Lifesciences Limited continues to operate as an established participant in the agrochemical sector with activities spanning manufacturing, importing, and exporting of crop protection products. The company’s diversified business model, regulatory focus, and market presence across domestic and international territories outline its operational breadth within the industry.

The IPO proceeds are intended for business expansion, capacity enhancement, and working capital needs, aligning with the company’s ongoing plans to strengthen its manufacturing infrastructure. Investors can review the details and apply through authorised trading platforms or banking channels as per the specified process and schedule.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Mahamaya Lifesciences IPO allotment status. 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.6 App Rating

icon-with-text

4 Languages

icon-with-text

₹6,800+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|